ReShape Lifesciences (RSLS)

• Market cap: $3.12M
• 1 day: -2.01%
• 5 days: -10.43%
• 1 month: -13.10%
• 3 months: -32.62%
• 6 months: -59.93%
• Year to date: -71.69%
• 1 year: -75.32%
• 5 years: -99.98%
• 10 years: -99.98%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.

Employees: 31

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

1.41% less ownership

Funds ownership: 1.65% [Q2] → 0.25% (-1.41%) [Q3]

38% less funds holding

Funds holding: 16 [Q2] → 10 (-6) [Q3]

67% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 9

90% less capital invested

Capital invested by funds: $73.3K [Q2] → $7.16K (-$66.1K) [Q3]

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 5